US Stock MarketDetailed Quotes

ARQT Arcutis Biotherapeutics

Watchlist
  • 8.490
  • -0.010-0.12%
Close Aug 16 16:00 ET
  • 8.520
  • +0.030+0.35%
Post 20:01 ET
992.40MMarket Cap-4994P/E (TTM)

Arcutis Biotherapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
494.57%30.86M
1,682.42%49.57M
1,517.09%59.61M
356.81%13.53M
5,156.41%38.11M
5.19M
2.78M
3.69M
2.96M
725K
Operating revenue
546.92%30.86M
675.58%21.57M
691.81%29.19M
356.81%13.53M
1,018.48%8.11M
--4.77M
--2.78M
--3.69M
--2.96M
--725K
Cost of revenue
346.39%3.46M
315.84%3.26M
561.41%4.99M
363.09%2.25M
339.41%1.18M
776K
783K
754K
485K
269K
Gross profit
520.62%27.39M
2,217.97%46.31M
1,762.86%54.62M
355.57%11.28M
7,998.03%36.93M
4.41M
2M
2.93M
2.48M
456K
Operating expense
8.84%77.47M
-0.42%77.94M
-2.90%295.72M
2.18%72.45M
-29.82%73.83M
8.13%71.18M
24.96%78.26M
47.47%304.56M
-0.54%70.9M
84.32%105.2M
Selling and administrative expenses
26.58%58.17M
27.67%54.79M
51.60%185.15M
31.47%48.67M
34.17%47.6M
66.38%45.96M
95.03%42.92M
100.30%122.12M
97.69%37.02M
115.33%35.47M
Research and development costs
-23.48%19.3M
-34.53%23.14M
-39.39%110.58M
-29.82%23.78M
-62.38%26.24M
-33.99%25.22M
-12.99%35.35M
25.33%182.44M
-35.54%33.88M
71.73%69.73M
Operating profit
24.99%-50.08M
58.54%-31.62M
20.07%-241.1M
10.60%-61.17M
64.77%-36.9M
-1.42%-66.76M
-21.77%-76.27M
-46.05%-301.63M
4.01%-68.42M
-83.52%-104.75M
Net non-operating interest income expense
-1.84%-7.48M
-6.22%-7.48M
-89.83%-29.71M
-12.25%-7.76M
-54.30%-7.56M
-267.45%-7.35M
-283.13%-7.04M
-15.65M
-6.92M
-4.9M
Non-operating interest expense
1.84%7.48M
6.22%7.48M
89.83%29.71M
12.25%7.76M
54.30%7.56M
267.45%7.35M
283.13%7.04M
--15.65M
--6.92M
--4.9M
Other net income (expense)
67.54%5.23M
26.10%4.04M
102.47%11.79M
-19.52%2.67M
40.40%2.72M
641.33%3.12M
2,158.45%3.21M
3,264.74%5.82M
8,400.00%3.32M
1,877.55%1.94M
Other non- operating income (expenses)
67.54%5.23M
26.10%4.04M
102.47%11.79M
-19.52%2.67M
40.40%2.72M
641.33%3.12M
2,158.45%3.21M
3,264.74%5.82M
8,400.00%3.32M
1,877.55%1.94M
Income before tax
26.28%-52.33M
56.23%-35.06M
16.83%-259.03M
8.00%-66.26M
61.25%-41.74M
-5.32%-70.99M
-24.53%-80.1M
-50.93%-311.46M
-0.97%-72.02M
-89.03%-107.71M
Income tax
0
324K
3.11M
25K
3.02M
0
0
0
0
0
Net income
26.28%-52.33M
55.83%-35.38M
15.83%-262.14M
7.96%-66.28M
58.44%-44.77M
-5.32%-70.99M
-24.53%-80.1M
-50.93%-311.46M
-0.97%-72.02M
-89.03%-107.71M
Net income continuous Operations
26.28%-52.33M
55.83%-35.38M
15.83%-262.14M
7.96%-66.28M
58.44%-44.77M
-5.32%-70.99M
-24.53%-80.1M
-50.93%-311.46M
-0.97%-72.02M
-89.03%-107.71M
Minority interest income
Net income attributable to the parent company
26.28%-52.33M
55.83%-35.38M
15.83%-262.14M
7.96%-66.28M
58.44%-44.77M
-5.32%-70.99M
-24.53%-80.1M
-50.93%-311.46M
-0.97%-72.02M
-89.03%-107.71M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
26.28%-52.33M
55.83%-35.38M
15.83%-262.14M
7.96%-66.28M
58.44%-44.77M
-5.32%-70.99M
-24.53%-80.1M
-50.93%-311.46M
-0.97%-72.02M
-89.03%-107.71M
Basic earnings per share
63.79%-0.42
75.57%-0.32
33.22%-3.78
38.98%-0.72
61.38%-0.73
11.45%-1.16
-3.15%-1.31
-35.41%-5.66
16.90%-1.18
-65.79%-1.89
Diluted earnings per share
63.79%-0.42
75.57%-0.32
33.22%-3.78
38.98%-0.72
61.38%-0.73
11.45%-1.16
-3.15%-1.31
-35.41%-5.66
16.90%-1.18
-65.79%-1.89
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 494.57%30.86M1,682.42%49.57M1,517.09%59.61M356.81%13.53M5,156.41%38.11M5.19M2.78M3.69M2.96M725K
Operating revenue 546.92%30.86M675.58%21.57M691.81%29.19M356.81%13.53M1,018.48%8.11M--4.77M--2.78M--3.69M--2.96M--725K
Cost of revenue 346.39%3.46M315.84%3.26M561.41%4.99M363.09%2.25M339.41%1.18M776K783K754K485K269K
Gross profit 520.62%27.39M2,217.97%46.31M1,762.86%54.62M355.57%11.28M7,998.03%36.93M4.41M2M2.93M2.48M456K
Operating expense 8.84%77.47M-0.42%77.94M-2.90%295.72M2.18%72.45M-29.82%73.83M8.13%71.18M24.96%78.26M47.47%304.56M-0.54%70.9M84.32%105.2M
Selling and administrative expenses 26.58%58.17M27.67%54.79M51.60%185.15M31.47%48.67M34.17%47.6M66.38%45.96M95.03%42.92M100.30%122.12M97.69%37.02M115.33%35.47M
Research and development costs -23.48%19.3M-34.53%23.14M-39.39%110.58M-29.82%23.78M-62.38%26.24M-33.99%25.22M-12.99%35.35M25.33%182.44M-35.54%33.88M71.73%69.73M
Operating profit 24.99%-50.08M58.54%-31.62M20.07%-241.1M10.60%-61.17M64.77%-36.9M-1.42%-66.76M-21.77%-76.27M-46.05%-301.63M4.01%-68.42M-83.52%-104.75M
Net non-operating interest income expense -1.84%-7.48M-6.22%-7.48M-89.83%-29.71M-12.25%-7.76M-54.30%-7.56M-267.45%-7.35M-283.13%-7.04M-15.65M-6.92M-4.9M
Non-operating interest expense 1.84%7.48M6.22%7.48M89.83%29.71M12.25%7.76M54.30%7.56M267.45%7.35M283.13%7.04M--15.65M--6.92M--4.9M
Other net income (expense) 67.54%5.23M26.10%4.04M102.47%11.79M-19.52%2.67M40.40%2.72M641.33%3.12M2,158.45%3.21M3,264.74%5.82M8,400.00%3.32M1,877.55%1.94M
Other non- operating income (expenses) 67.54%5.23M26.10%4.04M102.47%11.79M-19.52%2.67M40.40%2.72M641.33%3.12M2,158.45%3.21M3,264.74%5.82M8,400.00%3.32M1,877.55%1.94M
Income before tax 26.28%-52.33M56.23%-35.06M16.83%-259.03M8.00%-66.26M61.25%-41.74M-5.32%-70.99M-24.53%-80.1M-50.93%-311.46M-0.97%-72.02M-89.03%-107.71M
Income tax 0324K3.11M25K3.02M00000
Net income 26.28%-52.33M55.83%-35.38M15.83%-262.14M7.96%-66.28M58.44%-44.77M-5.32%-70.99M-24.53%-80.1M-50.93%-311.46M-0.97%-72.02M-89.03%-107.71M
Net income continuous Operations 26.28%-52.33M55.83%-35.38M15.83%-262.14M7.96%-66.28M58.44%-44.77M-5.32%-70.99M-24.53%-80.1M-50.93%-311.46M-0.97%-72.02M-89.03%-107.71M
Minority interest income
Net income attributable to the parent company 26.28%-52.33M55.83%-35.38M15.83%-262.14M7.96%-66.28M58.44%-44.77M-5.32%-70.99M-24.53%-80.1M-50.93%-311.46M-0.97%-72.02M-89.03%-107.71M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 26.28%-52.33M55.83%-35.38M15.83%-262.14M7.96%-66.28M58.44%-44.77M-5.32%-70.99M-24.53%-80.1M-50.93%-311.46M-0.97%-72.02M-89.03%-107.71M
Basic earnings per share 63.79%-0.4275.57%-0.3233.22%-3.7838.98%-0.7261.38%-0.7311.45%-1.16-3.15%-1.31-35.41%-5.6616.90%-1.18-65.79%-1.89
Diluted earnings per share 63.79%-0.4275.57%-0.3233.22%-3.7838.98%-0.7261.38%-0.7311.45%-1.16-3.15%-1.31-35.41%-5.6616.90%-1.18-65.79%-1.89
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg